J Gen Virol Try Microbiology Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 78 (1997), 757-765
© 1997 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rimmelzwaan, G. F.
Right arrow Articles by Osterhaus, A. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rimmelzwaan, G. F.
Right arrow Articles by Osterhaus, A. D.
Agricola
Right arrow Articles by Rimmelzwaan, G. F.
Right arrow Articles by Osterhaus, A. D.

Journal of General Virology, Vol 78, 757-765, Copyright © 1997 by Society for General Microbiology


ARTICLES

Induction of protective immunity against influenza virus in a macaque model: comparison of conventional and iscom vaccines

GF Rimmelzwaan, M Baars, R van Beek, G van Amerongen, K Lovgren-Bengtsson, EC Claas and AD Osterhaus
Department of Virology, Erasmus University Hospital Rotterdam, The Netherlands.

Cynomolgus macaque monkeys (Macaca fascicularis) were immunized twice intramuscularly, either with a conventional non-adjuvanted subunit vaccine or with a candidate immune-stimulating complex (iscom) vaccine, each containing 10 micrograms envelope glycoprotein of a recent human influenza A(H3N2) virus (A/Netherlands/18/94). In contrast to the macaques vaccinated with the classical subunit vaccine, those immunized with the iscom vaccine developed high titres of specific IgM, IgA and IgG serum antibodies, as well as high titres of haemagglutination- inhibiting and virus-neutralizing serum antibodies. Also, specific proliferative T cell responses were only found in the iscom-vaccinated monkeys and their levels were similar to those found in monkeys experimentally infected with the homologous virus. Upon intratracheal challenge with the homologous virus, the iscom-vaccinated monkeys were completely protected from detectable virus replication in lungs, pharynx and nose, whereas those vaccinated with the classical subunit vaccines were not, or were only partially protected. The kinetics of specific serum antibody development in the iscom-vaccinated monkeys after challenge were quite similar to those of monkeys after secondary infection with the same virus. In contrast, the post-challenge kinetics of serum antibody development in the monkeys vaccinated with the classical subunit vaccines resembled those of naive monkeys, confirming that these vaccines only provided limited protection in such animals.


This article has been cited by other articles:


Home page
J. Virol.Home page
C. R. Baskin, H. Bielefeldt-Ohmann, A. Garcia-Sastre, T. M. Tumpey, N. Van Hoeven, V. S. Carter, M. J. Thomas, S. Proll, A. Solorzano, R. Billharz, et al.
Functional Genomic and Serological Analysis of the Protective Immune Response Resulting from Vaccination of Macaques with an NS1-Truncated Influenza Virus
J. Virol., November 1, 2007; 81(21): 11817 - 11827.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
D. van Riel, V. J. Munster, E. de Wit, G. F. Rimmelzwaan, R. A.M. Fouchier, A. D.M.E. Osterhaus, and T. Kuiken
Human and Avian Influenza Viruses Target Different Cells in the Lower Respiratory Tract of Humans and Other Mammals
Am. J. Pathol., October 1, 2007; 171(4): 1215 - 1223.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. Baas, C. R. Baskin, D. L. Diamond, A. Garcia-Sastre, H. Bielefeldt-Ohmann, T. M. Tumpey, M. J. Thomas, V. S. Carter, T. H. Teal, N. Van Hoeven, et al.
Integrated Molecular Signature of Disease: Analysis of Influenza Virus-Infected Macaques through Functional Genomics and Proteomics
J. Virol., November 1, 2006; 80(21): 10813 - 10828.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. de Wit, V. J. Munster, M. I. J. Spronken, T. M. Bestebroer, C. Baas, W. E. P. Beyer, G. F. Rimmelzwaan, A. D. M. E. Osterhaus, and R. A. M. Fouchier
Protection of Mice against Lethal Infection with Highly Pathogenic H7N7 Influenza A Virus by Using a Recombinant Low-Pathogenicity Vaccine Strain
J. Virol., October 1, 2005; 79(19): 12401 - 12407.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
G. F. Rimmelzwaan, T. Kuiken, G. van Amerongen, T. M. Bestebroer, R. A. M. Fouchier, and A. D. M. E. Osterhaus
Pathogenesis of Influenza A (H5N1) Virus Infection in a Primate Model
J. Virol., July 15, 2001; 75(14): 6687 - 6691.
[Abstract] [Full Text]


Home page
J. Clin. Microbiol.Home page
R. A. M. Fouchier, T. M. Bestebroer, S. Herfst, L. Van Der Kemp, G. F. Rimmelzwaan, and A. D. M. E. Osterhaus
Detection of Influenza A Viruses from Different Species by PCR Amplification of Conserved Sequences in the Matrix Gene
J. Clin. Microbiol., November 1, 2000; 38(11): 4096 - 4101.
[Abstract] [Full Text]


Home page
J. Clin. Microbiol.Home page
J. T. M. Voeten, J. Groen, D. van Alphen, E. C. J. Claas, R. de Groot, A. D. M. E. Osterhaus, and G. F. Rimmelzwaan
Use of Recombinant Nucleoproteins in Enzyme-Linked Immunosorbent Assays for Detection of Virus-Specific Immunoglobulin A (IgA) and IgG Antibodies in Influenza Virus A- or B-Infected Patients
J. Clin. Microbiol., December 1, 1998; 36(12): 3527 - 3531.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1997 by the Society for General Microbiology.